Association of Alzheimer's disease GWAS loci with MRI markers of brain aging

Whether novel risk variants of Alzheimer's disease (AD) identified through genome-wide association studies also influence magnetic resonance imaging-based intermediate phenotypes of AD in the general population is unclear. We studied association of 24 AD risk loci with intracranial volume, total brain volume, hippocampal volume (HV), white matter hyperintensity burden, and brain infarcts in a meta-analysis of genetic association studies from large population-based samples (N = 8175-11,550). In single-SNP based tests, AD risk allele of APOE (rs2075650) was associated with smaller HV (p = 0.0054) and CD33 (rs3865444) with smaller intracranial volume (p = 0.0058). In gene-based tests, there was associations of HLA-DRB1 with total brain volume (p = 0.0006) and BIN1 with HV (p = 0.00089). A weighted AD genetic risk score was associated with smaller HV (beta ± SE = -0.047 ± 0.013, p = 0.00041), even after excluding the APOE locus (p = 0.029). However, only association of AD genetic risk score with HV, including APOE, was significant after multiple testing correction (including number of independent phenotypes tested). These results suggest that novel AD genetic risk variants may contribute to structural brain aging in nondemented older community persons.

[1]  C. Jack,et al.  Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers , 2013, The Lancet Neurology.

[2]  Agatha D. Lee,et al.  Apolipoprotein E genotype is associated with temporal and hippocampal atrophy rates in healthy elderly adults: a tensor-based morphometry study. , 2011, Journal of Alzheimer's disease : JAD.

[3]  Bonnie K. Lind,et al.  Infarctlike lesions in the brain: prevalence and anatomic characteristics at MR imaging of the elderly--data from the Cardiovascular Health Study. , 1997, Radiology.

[4]  Johanna Huttenlocher-Moser Variant of TREM2 Associated with the Risk of Alzheimer's Disease , 2013 .

[5]  V. Pankratz,et al.  Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease , 2009, Nature Genetics.

[6]  Nilüfer Ertekin-Taner,et al.  Late-onset Alzheimer disease genetic variants in posterior cortical atrophy and posterior AD , 2014, Neurology.

[7]  H. Markus,et al.  The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.

[8]  V. Gudnason,et al.  Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics. , 2007, American journal of epidemiology.

[9]  F. Fazekas,et al.  MRI white matter hyperintensities , 1999, Neurology.

[10]  Qiong Yang,et al.  The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. , 2007, American journal of epidemiology.

[11]  A Hofman,et al.  Homocysteine and brain atrophy on MRI of non-demented elderly. , 2003, Brain : a journal of neurology.

[12]  Carole Dufouil,et al.  White matter lesions volume and motor performances in the elderly , 2009, Annals of neurology.

[13]  M. Fornage,et al.  Genome-Wide Association Studies of MRI-Defined Brain Infarcts: Meta-Analysis From the CHARGE Consortium , 2010, Stroke.

[14]  Alzheimer's Disease Neuroimaging Initiative,et al.  Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer's disease , 2011, Molecular Psychiatry.

[15]  Harald Hampel,et al.  Reduced Hippocampal Volume in Healthy Young ApoE4 Carriers: An MRI Study , 2012, PloS one.

[16]  A. Mauleon,et al.  ATP5H/KCTD2 locus is associated with Alzheimer's disease risk , 2013, Molecular Psychiatry.

[17]  Paul M. Thompson,et al.  Common variants at 12q14 and 12q24 are associated with hippocampal volume , 2012, Nature Genetics.

[18]  D. G. Clark,et al.  Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease , 2011, Nature Genetics.

[19]  F. Fazekas,et al.  Apolipoprotein E4allele in the normal elderly: neuropsychologic and brain MRI correlates , 1996, Clinical genetics.

[20]  Keith A. Johnson,et al.  CD33 Alzheimer’s disease locus: Altered monocyte function and amyloid biology , 2013, Nature Neuroscience.

[21]  P. Visscher,et al.  A versatile gene-based test for genome-wide association studies. , 2010, American journal of human genetics.

[22]  P. Bosco,et al.  Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease , 2009, Nature Genetics.

[23]  L. Fratiglioni,et al.  The influence of APOE and TOMM40 polymorphisms on hippocampal volume and episodic memory in old age , 2013, Front. Hum. Neurosci..

[24]  J. Kaye,et al.  Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia , 1997, Neurology.

[25]  Karen L. Mohlke,et al.  Novel Loci for Adiponectin Levels and Their Influence on Type 2 Diabetes and Metabolic Traits: A Multi-Ethnic Meta-Analysis of 45,891 Individuals , 2012, PLoS genetics.

[26]  J. Trojanowski,et al.  Cognitive and functional resilience despite molecular evidence of Alzheimer’s disease pathology , 2013, Alzheimer's & Dementia.

[27]  C. Jack,et al.  MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers , 2008, Brain : a journal of neurology.

[28]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[29]  Jonas Persson,et al.  Reduced hippocampal volume in non-demented carriers of the apolipoprotein E ɛ4: Relation to chronological age and recognition memory , 2006, Neuroscience Letters.

[30]  C. Duijn,et al.  Heritability of fasting glucose levels in a young genetically isolated population , 2006, Diabetologia.

[31]  Ole A. Andreassen,et al.  A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline , 2012, Nature.

[32]  L. Kiemeney,et al.  Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer , 2009, Nature Genetics.

[33]  M. Marazita,et al.  Genome-wide Association Studies , 2012, Journal of dental research.

[34]  W. Gauderman Sample size requirements for association studies of gene-gene interaction. , 2002, American journal of epidemiology.

[35]  Mert Sabuncu,et al.  Genetic variation and neuroimaging measures in Alzheimer disease. , 2010, Archives of neurology.

[36]  H. Soininen,et al.  SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[37]  Nick C Fox,et al.  Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes , 2009, Nature Genetics.

[38]  Oscar L. Lopez,et al.  Evaluation of Dementia in the Cardiovascular Health Cognition Study , 2003, Neuroepidemiology.

[39]  D. Nyholt A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. , 2004, American journal of human genetics.

[40]  Meike W. Vernooij,et al.  The Rotterdam Study: 2014 objectives and design update , 2013, European Journal of Epidemiology.

[41]  Nick C Fox,et al.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.

[42]  W James Gauderman,et al.  Sample size requirements for matched case‐control studies of gene–environment interaction , 2002, Statistics in medicine.

[43]  A. Saykin,et al.  APOE genotype and neuroimaging markers of Alzheimer's disease: systematic review and meta-analysis , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[44]  Nick C Fox,et al.  Common variants in ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease , 2011, Nature Genetics.

[45]  Sudha Seshadri,et al.  Genome-wide analysis of genetic loci associated with Alzheimer disease. , 2010, JAMA.

[46]  H. Soininen,et al.  Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes , 1995, Neuroscience.

[47]  A. Folsom,et al.  Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. , 1999, Stroke.

[48]  Anne Corbett,et al.  Alzheimer's disease , 2011, The Lancet.

[49]  T. Dawber,et al.  The Framingham Study , 2014 .

[50]  A. M. Saunders,et al.  Apolipoprotein E ϵ4 allele and hippocampal volume in twins with normal cognition , 1997, Neurology.

[51]  L. Fried,et al.  Cardiovascular Health Study The Association of Alcohol Consumption and Incident Heart Failure: The , 2011 .

[52]  A Hofman,et al.  Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes , 2002, Neurology.

[53]  H. Soininen,et al.  Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E ϵ4 allele , 1995, Neurology.

[54]  Daniel Bandy,et al.  Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease , 1998, Annals of neurology.

[55]  Norbert Schuff,et al.  Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls , 2009, NeuroImage.

[56]  K. Lunetta,et al.  Methods in Genetics and Clinical Interpretation Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Design of Prospective Meta-Analyses of Genome-Wide Association Studies From 5 Cohorts , 2010 .

[57]  C. Jack,et al.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.

[58]  V. Gudnason,et al.  Coronary Artery Calcium, Brain Function and Structure: The AGES-Reykjavik Study , 2010, Stroke.

[59]  P. Wolf,et al.  The lifetime risk of stroke: estimates from the Framingham Study. , 2006, Stroke.

[60]  Reinhold Schmidt,et al.  Common variants at 6q22 and 17q21 are associated with intracranial volume , 2013, Nature Genetics.

[61]  P. Koudstaal,et al.  Silent brain infarcts: a systematic review , 2007, The Lancet Neurology.

[62]  M. Fornage,et al.  Genome‐wide association studies of cerebral white matter lesion burden , 2011, Annals of neurology.